Senior Director, Clinical Pharmacology

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.

The Role:

The Senior Director, Clinical Pharmacology is responsible for developing clinical pharmacology plans and overseeing the execution of these plans across therapeutic areas and in all phases of clinical development. This leadership role will have direct reports and is an integral member of the project team and serves as the clinical pharmacology and pharmacometrics lead for individual asset(s). This person designs and interprets clinical pharmacology studies and writes relevant sections of regulatory documents, protocols, and study reports. They use exploratory data analyses techniques, modeling, and simulations to accelerate development and support dosing, study designs, and development plans. They perform pharmacometrics analyses or provide scientific oversight of pharmacometrics analyses performed by external resources.

Key Responsibilities:

Serve as the head of clinical pharmacology and leader of the function for all indications Develop clinical pharmacology strategy for all Immunovant compounds and design, interpret, and conduct clinical pharmacology studies Provide clinical pharmacology support for Ph 1, 2, and 3 studies Support clinical pharmacology aspects of regulatory submissions including writing and review of relevant sections Provide data analyses, modeling and simulation to support asset development; perform pharmacometrics analyses or provide scientific oversight of pharmacometrics analyses performed by external resources. Collaborate closely with Regulatory to provide CP support of regulatory documents, communications, and presentations as needed (IND, health authority inquires, preparation/participation in meetings with health authorities, preparation of relevant BLA sections, addressing review inquiries, health authority sponsored Advisory Committee Meetings). Support cross-functional teams, including Statistics, Data Management, Clinical, Preclinical/Nonclinical, Translational Science, as needed.

Requirements:

• PhD, PharmD, or MD with training in CP, PK/PD, Pharmacology, and Pharmaceutical Sciences.

8-10 years of experience in the application of CP within the context of drug development in the healthcare industry.

• Experience in leadership of CP regulatory submission and approvals of at least one original or major NDA/CTDs or multiple supplemental NDA/CTDs (global or regional)
• Proven track record of clinical pharmacology and pharmacokinetic / pharmacometrics support for regulatory submissions (e.g., EoP2, IND, NDA, MAA, PIP)
• Experience and expertise with pharmacokinetics / pharmacometrics methods and software (e.g, NONMEM, WinNonlin)
• Deep understanding of drug development and the integration across the various functions including nonclinical, clinical, CMC, regulatory, finance and legal.
• Knowledge of regulatory expectations for clinical pharmacology
• Excellent written and oral communication skills with meticulous attention to detail.
• Thrives in a dynamic, interactive, fast-paced, innovative, and entrepreneurial environment.
• Natural collaborator who enjoys working on a cross-functional team.

Work Environment:

• Immunovant’s headquarters is located in New York City. The position is flexible for remote work.
• Dynamic, interactive, fast-paced, and entrepreneurial environment
• Domestic or international travel may be required (<10%).
• Salary range for posting

$250,000—$305,000 USD Compensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.